The economic issue of vascular access within the Japanese medical reimbursement system

Yoshiaki Takemoto1, Toshihide Naganuma1

  • 1Department of Urology, Osaka City University Graduate School of Medicine, Osaka - Japan.

Insights

Vascular access (VA) costs in Japan reach JPY20 billion annually, similar to the US. Percutaneous transluminal angioplasty (PTA) is increasingly vital for chronic renal failure treatment.

Area of Science:

  • Health Economics
  • Nephrology
  • Vascular Surgery

Background:

  • Vascular access (VA) is crucial for chronic renal failure (CRF) patients undergoing dialysis.
  • Understanding the economic burden of VA procedures is essential for healthcare planning.

Purpose of the Study:

  • To analyze the current health economics of VA procedures in Japan.
  • To compare VA-related healthcare costs in Japan with those in the USA.
  • To evaluate the trend and significance of percutaneous transluminal angioplasty (PTA) in VA procedures for CRF.

Main Methods:

  • Analysis of VA-related medical expenses in Japan.
  • Comparison with United States Renal Data System (USRDS) statistics for the USA.
  • Examination of the proportion and trend of PTA among VA procedures.

Main Results:

  • Yearly VA-related medical expenses in Japan amount to JPY20 billion, representing 1.4% of total CRF healthcare costs.
  • VA-related costs in Japan are comparable to the 1.2% seen in the USA.
  • Percutaneous transluminal angioplasty (PTA) constitutes approximately 60% of VA procedures in Japan, with this proportion increasing annually.

Conclusions:

  • Health economics of VA procedures in Japan are substantial and comparable to the US.
  • The increasing utilization of PTA suggests its growing importance in managing CRF.
  • Societal aging and extended treatment durations are likely to further elevate the significance of PTA for CRF patients in Japan.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
208
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
239
Ethical Issues01:27

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
2.1K
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.2K
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
786
Seedless Vascular Plants03:24

Seedless Vascular Plants

Seedless Vascular Plants Were the First Tall Plants on Earth
66.8K